Results 11 to 20 of about 212,078 (304)

Angiotensin-converting Enzyme Genetic Polymorphism

Arquivos Brasileiros de Cardiologia, 2014
Sir Editor, The recent report on "angiotensin-converting enzyme (ACE) genetic polymorphism." is very interesting. Albuquerque et al.1 concluded that "the DD genotype was independently associated with worse echocardiographic outcome, while the DI genotype, with best echocardiographic profile." In fact, the polymorphism of ACE is different in ...
Somsri Wiwanitkit, Viroj Wiwanitkit
doaj   +3 more sources

Angiotensin-Converting Enzyme Inhibitor / Angiotensin II Receptor Blocker in COVID-19: a Double-edged Sword or a Myth

Nepalese Medical Journal, 2020
Angiotensin-converting enzyme-2 receptor has been unearthed as a prime site of entry of Severe Acute Respiratory Syndrome Coronavirus 2 owing to its strong affinity towards spike protein of Severe Acute Respiratory Syndrome Coronavirus 2, resulting in ...
Kunal Bikram Shaha, Ashok Adhikari, Jung Rae Cho, Bimal Pandey, Yubaraj Sharma, Sajjad Safi   +5 more
doaj   +1 more source

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2

Frontiers in Pharmacology, 2020
BackgroundThe importance of dietary potassium in health and disease has been underestimated compared with that placed on dietary sodium. Larger effort has been made on reduction of sodium intake and less on the adequate dietary potassium intake, although
Carlos P. Vio, Carlos P. Vio, Pedro Gallardo, Carlos Cespedes, Carlos Cespedes, Daniela Salas, Jessica Diaz-Elizondo, Natalia Mendez   +7 more
doaj   +1 more source

Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2.

PLoS ONE, 2022
The outbreak of the coronavirus disease 2019 caused by the severe acute respiratory syndrome coronavirus 2 triggered a global pandemic where control is needed through therapeutic and preventive interventions. This study aims to identify natural compounds
Tomokazu Ohishi, Takayuki Hishiki, Mirza S Baig, Sajjan Rajpoot, Uzma Saqib, Tomohiko Takasaki, Yukihiko Hara   +6 more
doaj   +2 more sources

Variation of Concentrations of Angiotensin II, AngiotensinConverting Enzyme and Matrix Metalloprotease-9 in Tears and Serum of Patients with Diabetic Retinopathy

Oftalʹmologiâ, 2020
Diabetic retinopathy (DR) is becoming more and more widespread disease. Investigation of local changes of metabolic pathways in the eye improves our knowledge about diabetic retinopathy pathogenesis and provide perspective for the development of new ...
V. V. Neroev, N. B. Chesnokova, T. A. Pavlenko, T. D. Okhotsimskaya, O. V. Beznos, V. A. Fadeeva, S. V. Struchkova   +6 more
doaj   +1 more source

Angiotensin-converting Enzyme Inhibitors: Can it be a Potential Treatment of Infantile Hemangioma

Journal of Indian Association of Pediatric Surgeons, 2021
Aims: The aim of the sudy was to evaluate potential role of oral captopril, an angiotensin-converting enzyme (ACE) inhibitor, and in treatment of infantile hemagioma (IH) and report our preliminary results.
Archika Gupta, Shiv Narain Kureel, Anand Pandey, Gurmeet Singh, Akhilesh Kumar, Gaurav Shandilya, Rahul Kumar Rai, Survesh Kumar Gupta   +7 more
doaj   +1 more source

Angiotensin-Converting Enzyme Inhibitors [PDF]

Circulation, 1998
Abstract—ACE inhibitors have achieved widespread usage in the treatment of cardiovascular and renal disease. ACE inhibitors alter the balance between the vasoconstrictive, salt-retentive, and hypertrophic properties of angiotensin II (Ang II) and the vasodilatory and natriuretic properties of bradykinin and alter the metabolism of a number of other ...
N J, Brown, D E, Vaughan
openaire   +2 more sources

Identification of the SARS-CoV-2 Entry Receptor ACE2 as a Direct Target for Transcriptional Repression by Miz1

Frontiers in Immunology, 2021
Multiple lines of evidence have demonstrated that cigarette smoke or Chronic Obstructive Pulmonary Disease upregulates angiotensin-converting enzyme 2, the cellular receptor for the entry of the severe acute respiratory syndrome coronavirus 2, which ...
Jing Yang, Edith A. Perez, Changchun Hou, Pin Zhang, Michelle Van Scoyk, Robert A. Winn, Lijun Rong, Jing Liu   +7 more
doaj   +1 more source

A new angiotensin-converting enzyme inhibitor from Peperomia pellucida (L.) Kunth

Asian Pacific Journal of Tropical Biomedicine, 2019
Objective: To isolate, identify, and evaluate a new angiotensin-converting enzyme inhibitor from Peperomia pellucida (L.) Kunth herbs. Methods: A dried sample of Peperomia pellucida herb was successively macerated with n-hexane and ethyl acetate.
Islamudin Ahmad, Neneng Siti Silfi Ambarwati, Berna Elya, Hanita Omar, Kamarza Mulia, Arry Yanuar, Osamu Negishi, Abdul Mun´im   +7 more
doaj   +1 more source

Renin‐angiotensin aldosterone profile before and after angiotensin‐converting enzyme‐inhibitor administration in dogs with angiotensin‐converting enzyme gene polymorphism

Journal of Veterinary Internal Medicine, 2020
Background An angiotensin‐converting enzyme (ACE) gene polymorphism occurs in dogs; however, functional importance is not well studied. Hypothesis We hypothesized that dogs with the polymorphism would show alternative renin‐angiotensin aldosterone system
Darcy Adin, Clarke Atkins, Oliver Domenig, Teresa DeFrancesco, Bruce Keene, Sandra Tou, Joshua A. Stern, Kathryn M. Meurs   +7 more
doaj   +1 more source